Jay Lucidarme

3.5k citations
71 papers · 2.1k indexed · h-index 24
Topics
Bacterial Infections and Vaccines (71 papers)Pneumonia and Respiratory Infections (66 papers)Infective Endocarditis Diagnosis and Management (15 papers)

In The Last Decade

Jay Lucidarme

69 papers receiving 2.0k citations

Peers

Jay Lucidarme
Comparison fields: 5 of 60
  • Microbiology 1.9k
  • Epidemiology 1.8k
  • Public Health, Environmental and Occupational Health 160
  • Molecular Biology 141
  • Infectious Diseases 117
Replace Jamie Findlow with:
Jamie Findlow United Kingdom
Daniela Toneatto Italy
Jenny MacLennan United Kingdom
Xilian Bai United Kingdom
Tessa M. John United Kingdom
Rhonwen Morris United Kingdom
G Bjune Norway
Ellen Ypma Italy
Kihei Terada Japan
Jay Lucidarme relative to Jamie Findlow United Kingdom Jamie Findlow's profile →
Citations per field
00.5×
Jamie Findlow · 1×
Citations per year

Countries citing papers authored by Jay Lucidarme

Since Specialization
Citations

This map shows the geographic impact of Jay Lucidarme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Lucidarme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Lucidarme more than expected).

Fields of papers citing papers by Jay Lucidarme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Lucidarme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Lucidarme. The network helps show where Jay Lucidarme may publish in the future.

Co-authorship network of co-authors of Jay Lucidarme

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Lucidarme. A scholar is included among the top collaborators of Jay Lucidarme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Lucidarme. Jay Lucidarme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 0
5 1
6 18
7 3
8 10
9 12
10 3
11 10
12 13
13 13
14 61
15 16
16 163
17 49
18 168
19 120
20 85

About Jay Lucidarme

Jay Lucidarme is a scholar working on Microbiology, Epidemiology and Molecular Medicine, having authored 71 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (71 papers), Pneumonia and Respiratory Infections (66 papers) and Infective Endocarditis Diagnosis and Management (15 papers). The work is most often cited by research in Microbiology (1.9k citations), Epidemiology (1.8k citations) and Molecular Medicine (76 citations). Jay Lucidarme has collaborated with scholars based in United Kingdom, Italy and France. Frequent co-authors include Ray Borrow, Shamez Ladhani, Mary Ramsay, Jamie Findlow, Helen Campbell, Steve Gray, S. A. Clark, Mariagrazia Pizza, Sydel R. Parikh and Stephen J. Gray. Their work appears in journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026